Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA:600521)
26.59
+2.42 (10.01%)
Sep 1, 2025, 3:00 PM CST
SHA:600521 Revenue
Zhejiang Huahai Pharmaceutical had revenue of 2.15B CNY in the quarter ending June 30, 2025, a decrease of -18.32%. This brings the company's revenue in the last twelve months to 8.94B, down -2.27% year-over-year. In the year 2024, Zhejiang Huahai Pharmaceutical had annual revenue of 9.55B with 14.91% growth.
Revenue (ttm)
8.94B
Revenue Growth
-2.27%
P/S Ratio
4.43
Revenue / Employee
985.71K
Employees
9,065
Market Cap
39.63B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 9.55B | 1.24B | 14.91% |
Dec 31, 2023 | 8.31B | 42.97M | 0.52% |
Dec 31, 2022 | 8.27B | 1.62B | 24.42% |
Dec 31, 2021 | 6.64B | 158.36M | 2.44% |
Dec 31, 2020 | 6.49B | 1.10B | 20.36% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 30.15B |
WuXi AppTec | 41.90B |
Shenzhen Mindray Bio-Medical Electronics | 32.94B |
Sichuan Biokin Pharmaceutical | 441.19M |
Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.98B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |